Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease

P M Sweetnam1, H F Thomas, J W Yarnell

  • 1MRC Epidemiology Unit, Llandough Hospital, Penarth, U.K.

European Heart Journal
|December 1, 1996
PubMed

Insights

High fibrinogen and blood viscosity are strong, independent predictors of long-term ischaemic heart disease risk in men. These factors significantly increase the likelihood of developing heart disease over time.

Area of Science:

  • Cardiovascular Epidemiology
  • Hemodynamics
  • Biomarkers of Cardiovascular Disease

Background:

  • Ischaemic heart disease (IHD) remains a leading cause of mortality worldwide.
  • Identifying reliable predictors of IHD risk is crucial for effective prevention strategies.
  • Previous studies suggested roles for fibrinogen and blood viscosity, but long-term independent predictive power required further investigation.

Purpose of the Study:

  • To evaluate the ten-year predictive value of fibrinogen and blood viscosity for ischaemic heart disease risk.
  • To determine if fibrinogen and viscosity are independent predictors of IHD after accounting for other cardiovascular risk factors.

Main Methods:

  • Utilized ten-year follow-up data from the prospective Caerphilly and Speedwell studies.
  • Included a representative sample of middle-aged males (n=4860).
  • Defined IHD morbidity and mortality using hospital records, ECGs, and death certificates; analyzed 603 incident events.

Main Results:

  • Elevated levels of fibrinogen and viscosity were associated with significantly increased IHD risk (relative odds 3.3 and 3.4, respectively).
  • After adjusting for major cardiovascular risk factors, both fibrinogen (OR 2.2) and viscosity (OR 2.3) remained significant independent predictors.
  • Joint analysis confirmed both factors as significant predictors (P < 0.01), with increasing IHD incidence observed with higher levels of either marker.

Conclusions:

  • Fibrinogen and blood viscosity are powerful, long-term, and independent predictors of ischaemic heart disease risk.
  • These hemorheological markers provide valuable prognostic information beyond traditional risk factors.
  • Findings underscore the importance of considering fibrinogen and viscosity in cardiovascular risk assessment.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
831